167
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Failure due to formal reasons within German benefit assessment of medicinal products: the dilemma between marketing authorization and HTA

& ORCID Icon
Pages 145-157 | Received 02 Jul 2019, Accepted 10 Feb 2020, Published online: 20 Feb 2020

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.